Association of treatment delay and stage with mortality in breast cancer: a nationwide cohort study in Taiwan

[ad_1] Study design This retrospective cohort study was conducted to evaluate the impact of DFTI and other related factors on mortality among female breast cancer patients. Confirmed breast cancer cases diagnosed between 2011 and 2017 were sampled and their survival followed until the end of 2018. The start date of follow-up was the date of… Continue reading Association of treatment delay and stage with mortality in breast cancer: a nationwide cohort study in Taiwan

NHS England to offer ‘potentially life-saving’ drug for aggressive breast cancer | Breast cancer

[ad_1] Women with a particularly aggressive form of breast cancer have been given access to a “potentially life-saving” drug after NHS bosses reached a deal with its manufacturer. Up to 1,600 women a year will be able to receive pembrolizumab, which has the potential to make some of those who take it completely cancer-free, NHS… Continue reading NHS England to offer ‘potentially life-saving’ drug for aggressive breast cancer | Breast cancer